Single-Use Chromatography – a Feasible Unit Operation?
02nd July 2015 | 3AM EDT / 8AM BST / 9AM CEST / 4PM SGT | Dr. Joachim Walter & Dr. Günter Jagschies |WATCH FOR FREE
Dr Joachim Walter got his education and PhD at the RWTH Aachen, Germany, and started his industrial career at Boehringer Ingelheim, Germany, in 1985. Here he became involved in the planning and establishing of a biotech facility, specifically responsible for establishing and leading the R&D Protein Chemistry within the Biopharmaceutical Division. For nearly 18 years he was responsible for Process Development Downstream Processing, including four different scientific groups engaged in the development of downstream processes at laboratory scale, scale up and the cGMP manufacture of clinical grade biopharmaceutical proteins for clinical phases I and II in a 2,000 L pilot plant. Other important areas of work were the development of methodologies and processes for viral clearance as well as the planning and performance of validation studies for viral clearance. Beside such process related activities, the groups worked on the design, development and implementation of technical equipment for downstream processing of biopharmaceutical proteins. Dr Walter participated in the scientific presentation of Boehringer Ingelheim by numerous scientific papers, presentations at international congresses and educational seminars as well as participation in the planning and organization of international congresses.
In 2002 he accepted a management position at GE Healthcare, USA, as Unit VP Membrane Separation Sciences. He supported scientifically the establishment of new businesses such as Membrane Separations and Single-use Technology for GE Healthcare regarding industrial and regulatory requirements and applications in biopharmaceutical development and production processes.
In 2009 to 2012 Dr Walter cooperated with Innobiologics, Malaysia. As acting SVP Biopharmaceutical Operations at Innobiologics he was heading three departments including Process Sciences, Biomanufacturing and Facility Engineering.
Dr Walter provides consulting and is specialised in biopharmaceutical development and manufacturing, including project planning, development and manufacturing management, process design downstream processing, including development, application and implementation of single-use technologies, drug safety, documentation and validation.
Sponsored by GE Healthcare
GE Healthcare Life Sciences is a division of GE Healthcare, a part of the General Electric Company. The Life Sciences division provides tools and technologies, solutions and expertise that enable the biopharmaceutical industry to develop and manufacture biotherapeutic medicines and vaccines cost-effectively. Our products and platform solutions are designed to meet the key challenges posted at every stage in the biomanufacturing process, delivering the desired product at the required purity and safety: all with fast development and integrated solutions in mind. Across the bioprocessing spectrum, our focus is on supporting you from idea to result.
Günter represents the company in numerous technical and business oriented conferences and publications directed at the biopharmaceutical industry.
He is co-author of “Process Chromatography”, a recent handbook for the biopharmaceutical industry and co-editor and -author of “The Development of Therapeutic Monoclonal Antibody Products”, a comprehensive review and analysis of the Chemistry, Manufacturing, and Control (CMC) activities, economic conditions, and regulatory requirements for the development of therapeutic monoclonal antibody products.
Günter has published numerous papers on the development, manufacturing, and economics of biotherapeutics. In 2012 he received the BioProcess International Award as “Thought Leader of the Decade” in the Downstream Processing category. He is co-chairing the not-for-profit conference series BioProcessing Asia (BPA), which will run for the first time in Nov 2014. He is based in Uppsala, Sweden.